Exponent, Inc.
EXPO US30214U1025
Exponent Inc provides engineering and scientific consulting services on a project-by-project basis. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which accounts for the majority of revenue, provides servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 33% | -14% | -10% | -1% | 1% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Corrigan Catherine CEO |
69.77 USD |
3,226 Sold |
225,069 USD |
15/09/2025 | 15/09/2025 |
| Corrigan Catherine CEO |
70.18 USD |
1,679 Sold |
117,833 USD |
15/09/2025 | 15/09/2025 |
| Corrigan Catherine CEO |
70.18 USD |
1,679 Sold |
117,833 USD |
15/09/2025 | 15/09/2025 |
| Corrigan Catherine CEO |
71.38 USD |
1,670 Sold |
119,207 USD |
14/08/2025 | 14/08/2025 |
| Corrigan Catherine CEO |
70.93 USD |
3,226 Sold |
228,835 USD |
14/08/2025 | 14/08/2025 |
| Sala Joseph VP |
70.64 USD |
1,595 Sold |
112,672 USD |
12/08/2025 | 12/08/2025 |
| Rakow Joseph VP |
77.72 USD |
1,573 Sold |
122,254 USD |
27/05/2025 | 27/05/2025 |
| Rakow Joseph VP |
77.72 USD |
1,573 Sold |
122,254 USD |
27/05/2025 | 27/05/2025 |
| Pye John VP |
76.34 USD |
342 Sold |
26,108 USD |
23/05/2025 | 23/05/2025 |
| Pye John VP |
76.32 USD |
1,658 Sold |
126,530 USD |
23/05/2025 | 23/05/2025 |